Any feedback?
Literature summary for 3.4.17.21 extracted from
- Increased prostate-specific membrane antigen expression in LNCaP cells following treatment with bispecific antisense oligonucleotides directed against bcl-2 and EGFR (2009), Med. Oncol., 27, 1212-1218.
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | - |
- |
- |
Source Tissue
| Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|
| LNCaP cell | - |
Homo sapiens | - |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| Prostate-specific membrane antigen | - |
Homo sapiens |
| PSMA | - |
Homo sapiens |
Expression
| Organism | Comment | Expression |
|---|---|---|
| Homo sapiens | inhibition of LNCaP cell growth by mono- and bispecific antisense oligonucleotides directed against bcl-2 and epidermal growth factor receptor, EGFR, inhibition of expression of non-targeted proteins prostate-specific membrane antigen only by bcl-2-monospecific oligos, overview | down |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
